Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Astrocyte Dysfunction in Developmental Neurometabolic Diseases.
Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G.
Alteration of the cytokine signature by various TLR ligands in different T cell populations in MOG37-50 and MOG35-55-induced EAE in C57BL/6 mice.
The Dress: Transforming a web viral event into a scientific survey.
Are electrophysiological criteria useful in distinguishing childhood demyelinating neuropathies?
An investigation of commonly prescribed stretches of the ankle plantarflexors in people with Multiple Sclerosis.
Antigen-oriented T cell migration contributes to myelin peptide induced-EAE and immune tolerance.
Screening and characterization of molecules that modulate the biological activity of IFNs-I.
CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis.
Quantitative analysis of multiple sclerosis patients' preferences for drug treatment: a best-worst scaling study.
Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
A pilot study of changes in functional brain activity during a working memory task after mSMT treatment: The MEMREHAB trial.
Adult anaplastic pilocytic astrocytoma - a diagnostic challenge? A case series and literature review.
Dietary salt intake and time to relapse in paediatric multiple sclerosis.
Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
ASSOCIATION BETWEEN DISABILITY AND QUALITY OF LIFE IN MULTIPLE SCLEROSIS PATIENTS IN AHVAZ, IRAN.
The efficacy and safety of teriflunomide based therapy in patients with relapsing multiple sclerosis: A meta-analysis of randomized controlled trials.
Management Strategies for Flu-Like Symptoms and Injection-Site Reactions Associated with Peginterferon Beta-1a: Obtaining Recommendations Using the Delphi Technique.
Children with multiple sclerosis should not become therapeutic hostages.
Mutism Caused by Severe Demyelination in a Patient With Marchiafava-Bignami Disease.
Three cases of herpes zoster radiculitis in MS patients treated with natalizumab.
Neurological Manifestations in Familial Mediterranean Fever: Results of 22 Children from a Reference Center in Kayseri, an Urban Area in Central Anatolia, Turkey.
Yellow fever vaccine-associated neurotropic disease (YEL-AND) - A case report.
CADASIL mimicking multiple sclerosis: The importance of clinical and MRI red flags.
Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis.
Pages
« first
‹ previous
…
844
845
846
847
848
849
850
851
852
…
next ›
last »